because you are a biologist, let me ask you a few questions. If reslabrat is around, I'd like to hear your answers as well.
Which solid tumors or stage of cancer do you think would be the most amenable to vaccine treatment?
The reason I ask is because at a conference I was at last year, there was a debate regarding how well immune cells could penetrate a large primary tumor. The method that was being presented is different than ADXS/INO (something more like Provenge). The presenter did say that there is hesitation from big pharma for funding autologous transplants right now, which is a plus for ADXS.
Second Question: How do you think vaccine immunotherapy will compare to mAbs? For breast cancer, ADXS will be pursuing HER2+ cancers. With T-DM1 now approved, where do you see a vaccine fitting in?